High-fidelity Cas9-mediated targeting of KRAS driver mutations restrains lung cancer in preclinical models

ABSTRACT:

SUBMITTER: Alvarez-Perez J 

PROVIDER: S-EPMC12402321 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature